Skip to main content

Table 3 Tropism test results and response to treatment.

From: Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice

No.

age

(years)

gender

(m/f)

No. of previous regimens

S OBT:

cummulative

days between V3 analysis and MVC start

Predicted phenotype (V3) before MVC

FPR

(%)

TROFILE Phenotype before MVC

overall

response

Phenotype after failure

1

39

m

l

2,5

42

R5

38

-

sec.failure

X4 (FPR 16.6%)

2

56

m

16

3,0

36

R5

21,2

R5

sec.failure

R5 (FPR 23.7%)

3

54

m

9

2,0

26

R5

24,7

-

+

-

4

38

m

3

3,5

10

R5

23,4

D/M

+

-

5

43

m

3

2,1

38

R5

25

-

+

-

6

50

f

19

1,0

16

R5

38,3

-

+

-

7

47

f

15

2,0

57

R5

33,9

-

+

-

8

49

m

9

3,0

0

R5

79,5

-

sec.failure

-

9

46

m

1

3,0

205

R5

96,5

R5

+

 

10

40

m

11

2,5

30

R5

85,8

R5

sec.failure

R5 (FPR 65.4%)

11

38

m

2

1,5

49

R5

47,8

-

+

-

12

59

f

17

3,5

262

R5

82,4

-

sec.failure

X4 (FPR 74.3%)

13

55

m

17

4,6

187

R5

96,1

-

prim.failure

R5 (FPR 96.1)

14

67

m

16

3,0

40

X4

15,6

R5

+

-

15

64

m

5

3,0

275

X4

5,4

R5

+

-

16

47

m

15

0,5

282

R5

31,3

R5

sec.failure

X4 (FPR 11,4%)

17

50

m

6

2,5

10

R5

89,7

R5

(+)

-

18

52

f

15

4,0

0

X4

6

-

+

-

19

37

f

1

2,0

20

R5

64

R5

(+)

-

20

46

m

19

0,0

-

-

-

R5

prim.failure

X4 (TROFILE)

21

44

m

1

3,5

43

R5

85,6

-

(+)

 

22

48

f

6

2,0

76

R5

89,1

R5

sec.failure

R5 (FPR 76.9%)

23

35

m

13

1,5

210

X4

1,7

-

sec.failure

D/M (TROFILE)

24

40

m

9

3,0

43

R5

90,7

-

+

-

25

61

m

6

3,0

126

R5

42,6

R5

+

-

26

42

f

24

1,5

295

X4

9

-

+

-

27

61

f

1

3,5

30

R5

67

-

+

-

28

54

f

5

2,0

95

R5

80

R5

+

-

29

48

m

19

0,0

152

R5

67,9

-

sec.failure

R5 (FPR 49.7%)

30

50

m

11

3,6

227

R5

38,4

-

+

-

31

44

f

10

4,1

106

R5

91,2

-

sec.failure

X4 (FPR 6%)

32

30

f

7

2,0

31

R5

98,9

-

+

-

  1. + = sustained complete treatment response, (+) = partial treatment response, prim. = primary, sec. = secondary, D/M = dual/mixed.